tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF

Paradigm Biopharmaceuticals (PBIGF) Similar Stocks

Compare
17 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
$0.22
$84.88M
-7.03
7.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
AU$0.32
AU$99.33M
-1.01
-75.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$87.00M
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Pharmaust Limited
AU$0.10
€58.82M
-3.09
-38.24%
2 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.41
AU$179.29M
-6.77
38.64%
Arovella Therapeutics Limited
AU$0.08
AU$99.70M
-12.06
-54.44%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PBIGF
Paradigm Biopharmaceuticals
0.22
0.01
4.76%
AU:IMU
Imugene
0.32
-0.90
-73.86%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:NUZ
Pharmaust Limited
0.11
-0.06
-36.36%
AU:RCE
Recce Pharmaceuticals Ltd.
0.61
0.17
38.64%
AU:ALA
Arovella Therapeutics Limited
0.08
-0.10
-55.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts